Diethylhexylphthalate (DEHP), a rodent carcinogen, and 1,4-dichlorobenzene (DCB), a noncarcinogen in rat liver, are potent hepatomitogens. We have reported previously that 7-day dosing with DEHP induced a higher bromodeoxyuridine labeling index (LI) in binuclear octoploid (2×4N) rat hepatocytes than did DCB, suggesting that induction of DNA synthesis in 2×4N hepatocytes might represent a more substantial carcinogenic risk. We compared 2 additional rodent hepatocarcinogens, methylclofenapate (MCP) and phenobarbitone, with ethylene thiourea (ETU), a noncarcinogenic hepatomitogen in rat. All 3 chemicals increased hepatic LI; the 8N population had the highest LI, but only the carcinogens increased LI in the 2×4N and 4N populations. To identify the target population for induction of DNA synthesis, we used a 1-hour pulse label at the peak of induction. The results were consistent with the 7-day data, and again the highest LI was in the 8N population. The nongenotoxic rodent carcinogens MCP and DEHP induced a significant increase in the LI in the 2×4N population, whereas ETU and DCB did not. These data support the hypothesis that increased DNA synthesis within the minority 2×4N population may be more significant for subsequent hepatocarcinogenesis.
Ames BN, Gold LS ( 1990). Too many rodent cacinogens: Mitogenesis increases mutagenesis . Science249: 970-971.
2.
Ashby J., Tennant R. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutat Res257: 229-306.
3.
Azarnoff DL, Reddy J., Hignite C., Fitzgerald T. (1976). Structure activity relationships of clofibrate-like compounds and lipid metabolism. Proc 6th Int Pharmacol Meet4: 137-147.
4.
Bellamy Coc, Clarke AR, Wyllie AH, Harrison DJ (1997). p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J11: 591-599.
5.
Berry MN, Friend DS (1969). High yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J Cell Biol43: 506-520.
6.
Brodsky WY, Uryvaeva IV (1977). Cell ploidy: Its relation to tissue growth and function. Int Rev Cytol50: 275-332.
7.
Carriere R. (1969). The growth of liver parenchymal nuclei and its endocrine regulation. Int Rev Cytol25: 201-277.
8.
Freeman M., Tukey J. (1950). Transformations related to the angular and the square root. Ann Math Stat21: 607.
9.
Hasmall SC, Pyrah Itg, Soames AR, Roberts RA (1997). Expression of the Immediate early genes, c-fos, c-jun and c-myc: A comparison in rats of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Fundam Appl Toxicol40: 129-137.
10.
Hasmall SC, Roberts RA (1997). Hepatic ploidy, nuclearity and distribution of DNA synthesis: A comparison of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Toxicol Appl Pharmacol144: 287-293.
11.
Issemann I. , Green S. (1990). Activation of a member of the steroid hormoe receptor superfamily by peroxisome proliferators . Nature347:645-650.
12.
Lalwani ND, Dethloff LA, Haskins JR, Robertson DG, De La Inglesia FA (1997). Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver. Toxicol Pathol25: 165-176.
13.
Lee S., Pineau T., Drago J., Lee EJ, Owens JO, Kroetz DL, Fernandez-Salguero PM, Westphal H., Gonzalez FJ (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotrophic effects of peroxisome proliferators. Mol Cell Biol15: 3012-3022.
14.
Millar RT, Glover SE, Stewart WS, Corton JC, Popp JA, Cattley RC (1996). Effect of the expression of c-met, c-myc and PPAR-A in liver and liver tumours from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis17: 1337-1341.
15.
Millar RT, Shah RS, Cattley RC, Popp JA ( 1996). The peroxisome proliferators WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats. Toxicol Appl Pharmacol138: 317-323.
16.
National Toxicology Program ( 1982). Carcinogenesis Bioassay of Di(ethylhexyl)phthalate (CAS No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Study). Technical Report No 217, National Institutes of Health Publication No 82-1773, National Institutes of Health, Research Triangle Park, North Carolina .
17.
National Toxicology Program (1987). Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/ n Rats and B6C3F1 Mice. Technical Report No 319, National Institutes of Health Publication No 87-2575, National Institutes of Health, Research Triangle Park, North Carolina.
18.
National Toxicology Program (1992). Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS No. 96-45-7) in F344 Rats and B6C3F1 Mice. Technical Report No 388, National Institutes of Health, Research Triangle Park, North Carolina.
19.
Nebert D., Gonzalez F. (1987). P450 genes: Structure, evolution, and regulation . Annu Rev Biochem56: 945-993.
20.
Nelder JA, Wedderburn Rwm (1972). Generalised linear models. J R Stat Soc135: 370-384.
Oriyama T., Yamanaka N., Fujimoto J., Ichikawa N., Okamoto E. (1998). Progression of hepatocellular carcinoma as reflected by nuclear DNA ploidy and cellular differentiation. J Hepatol28: 142-149.
23.
Phillips J. , Price R., Cunninghame M., Osimitz T., Cockburn A., Gabriel K., Preiss F., Butler W., Lake B. (1997). Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats. Fundam Appl Toxicol38: 64-74.
24.
Reddy JK, Lalwani ND, Reddy K., Qureshi SA (1982). Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res42: 259-266.
25.
Rossi L., Ravera M., Repetti G., Santi L. (1977). Long-term administration of DDT or phenobarbital-Na in Wistar rats. Int J Cancer19:179-185.
26.
Saeter G., Schwarze PE, Nesland JM, Juul N., Pettersen EO, Seglen PO (1988). The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis9: 939-945.
27.
SAS Institute (1989). SAS/STAT User's Guide, version 6, 4th ed. SAS Institute, Cary, North Carolina.
28.
Schulte-Hermann R. (1974). Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol3: 97-158.
29.
Schulte-Hermann R., Hoffmann V., Landgraf H. (1980). Adaptive responses of the rat liver to the gestagen and antiandrogen cyproterone acetate and other inducers. III. Cytological changes. Chem-Biol Interact31: 301-311.
30.
Styles JA, Kelly M., Elcombe CR (1987). A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver. Carcinogenesis8: 391-399.
31.
Styles JA, Kelly M., Pritchard NR, Elcombe CR (1988). A species comparison of acute hyperplasia induced by the peroxisome proliferator methylcofenapate: Involvement of the binucleated hepatocyte. Carcinogenesis9: 1647-1655.
32.
Yin L., Ghebranious N., Chakraborty S., Sheehan CE, Ilic Z., Sell S. ( 1998). Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo. Hepatology27: 73-80.
